bioMérieux Stock Euronext Paris
Equities
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.18B 5.75B | Sales 2025 * | 4.19B 4.5B 6.18B | Capitalization | 11.71B 12.56B 17.25B |
---|---|---|---|---|---|
Net income 2024 * | 467M 501M 688M | Net income 2025 * | 527M 565M 776M | EV / Sales 2024 * | 2.93 x |
Net cash position 2024 * | 263M 283M 388M | Net cash position 2025 * | 444M 476M 653M | EV / Sales 2025 * | 2.69 x |
P/E ratio 2024 * |
25.7
x | P/E ratio 2025 * |
22.7
x | Employees | - |
Yield 2024 * |
0.87% | Yield 2025 * |
1.01% | Free-Float | 36.21% |
Latest transcript on bioMérieux
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 16-10-31 |
Chairman | 50 | 04-04-15 | |
Director of Finance/CFO | 47 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-09-14 | |
Director/Board Member | 63 | 04-12-31 | |
Chairman | 50 | 04-04-15 |
1st Jan change | Capi. | |
---|---|---|
+0.13% | 8.51B | |
-1.37% | 5.29B | |
+20.18% | 5.16B | |
-0.74% | 4.55B | |
-54.68% | 3.04B | |
+24.56% | 3B | |
+25.13% | 2.17B | |
-1.86% | 1.92B | |
+5.88% | 1.64B |